Abstract
Drug discovery has faced many challenges, and the diversity of natural products offers a huge number of opportunities for new drug findings. Most of the potential candidates result from plants since plants have several and interesting biological activities. However, the in vivo efficacy of such candidates is frequently limited due to their low absorption. Thus, enhancing the bioavailability of natural products through the improvement of their pharmacokinetic and biodistribution features, as well as their targeting efficacy, is a crucial step in the development of new therapeutic strategies.
Here, we reviewed nanotechnology as a rising approach for drug delivery, presenting smart nanocarriers that can selectively deliver appropriate levels of a therapeutic agent. Moreover, in order to deliver the therapeutic agent to target cells, nanocarriers can also be efficient targeting systems. Another benefit here discussed in the use of nanocarriers to deliver natural products is the controlled drug release.
This review describes many types of nanocarriers with structural and functional differences between them which can be chosen accordingly to the encapsulated drug characteristics, to the specific target, or even to the desired release rate. With regard to natural products, we highlight several natural products that are already being commercialized or in clinical study phase with impressive therapeutic improvements using these nanocarriers. On the other hand, there are also a large number of natural products that are being used as encapsulant material in pioneering nanocarriers. This review aims to summarize the development in several key areas relevant to natural products in nanopharmaceuticals. Besides the potential beneficial use, also attention is drawn to the question how we should proceed with the safety and efficacy evaluation of the nanopharmaceuticals for natural product delivery. Nonetheless, research into sophisticated, science-driven solutions is still continuing; expectations related to therapeutic efficacy are high to meet clinical needs, but the progress made has been noticeable.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbasi S, Paul A, Shao W, Prakash S (2012) Cationic albumin nanoparticles for enhanced drug delivery to treat breast Cancer: preparation and in vitro assessment. J Drug Deliv 2012:1–8. https://doi.org/10.1155/2012/686108
Abbasi E, Aval S, Akbarzadeh A, Milani M, Nasrabadi H, Joo S et al (2014) Dendrimers: synthesis, applications, and properties. Nanoscale Res Lett 9:1–10. https://doi.org/10.1186/1556-276X-9-247
Alexander A, Ajazuddin Patel RJ, Saraf S, Saraf S (2016) Recent expansion of pharmaceutical nanotechnologies and targeting strategies in the field of phytopharmaceuticals for the delivery of herbal extracts and bioactives. J Control Release 241:110–124. https://doi.org/10.1016/j.jconrel.2016.09.017
Ansari S, Sameem M, Islam F (2012) Influence of nanotechnology on herbal drugs: a review. J Adv Pharm Technol Res 3(3):142. https://doi.org/10.4103/2231-4040.101006
Anwunobi AP, Emeje MO (2011) Recent applications of natural polymers in nanodrug delivery. J Nanomedic Nanotechnol S4:002. https://doi.org/10.4172/2157-7439.S4-002
Aras A, Khokhar AR, Qureshi MZ, Silva MF, Sobczak-Kupiec A, Pineda EAG et al (2014) Targeting cancer with nano-bullets: curcumin, EGCG, resveratrol and quercetin on flying carpets. Asian Pac J Cancer Prev 15(9):3865–3871. https://doi.org/10.7314/APJCP.2014.15.9.3865
Asadi-Samani M, Kooti W, Aslani E, Shirzad H (2015) A systematic review of Iran’s medicinal plants with anticancer effects. J Evid Based Complement Alternat Med:1–11. https://doi.org/10.1177/2156587215600873
Bahmani M, Shirzad H, Shahinfard N, Sheivandi L, Rafieian-Kopaei M (2016) Cancer Phytotherapy: recent views on the role of antioxidant and angiogenesis activities. J Evid Based Complement Altern Med:1–11. https://doi.org/10.1177/2156587215625157
Banik BL, Fattahi P, Brown JL (2016) Polymeric nanoparticles: the future of nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol 8(2):271–299. https://doi.org/10.1002/wnan.1364
Barenholz Y (2012) Doxil® – the first FDA-approved nano-drug: lessons learned. J Control Release 160(2):117–134. https://doi.org/10.1016/j.jconrel.2012.03.020
Bawarski WE, Chidlowsky E, Bharali DJ, Mousa SA (2008) Emerging nanopharmaceuticals. Nanomedicine 4(4):273–282. https://doi.org/10.1016/j.nano.2008.06.002
Bernabeu E, Cagel M, Lagomarsino E, Moretton M, Chiappetta DA (2017) Paclitaxel: what has been done and the challenges remain ahead. Int J Pharm 526(1–2):474–495. https://doi.org/10.1016/j.ijpharm.2017.05.016
Bilia AR, Piazzini V, Guccione C, Risaliti L, Asprea M, Capecchi G, Bergonzi MC (2017) Improving on nature: the role of nanomedicine in the development of clinical natural drugs. Planta Med 83(5):366–381. https://doi.org/10.1055/s-0043-102949
Boehlke L, Winter JN (2006) Sphingomyelin/cholesterol liposomal vincristine: a new formulation for an old drug. Expert Opin Biol Ther 6(4):409–415. https://doi.org/10.1517/14712598.6.4.409
Bonifácio BV, Silva PB, Aparecido dos Santos Ramos M, Maria Silveira Negri K, Maria Bauab T, Chorilli M (2014) Nanotechnology-based drug delivery systems and herbal medicines: a review. Int J Nanomedicine 9(1):1–15. https://doi.org/10.2147/IJN.S52634
Borel T, Sabliov CM (2014) Nanodelivery of bioactive components for food applications: types of delivery systems, properties, and their effect on ADME profiles and toxicity of nanoparticles. Annu Rev Food Sci Technol 5(1):197–213. https://doi.org/10.1146/annurev-food-030713-092354
Burmistrova O, Simões MF, Rijo P, Quintana J, Bermejo J, Estévez F (2013) Antiproliferative activity of abietane diterpenoids against human tumor cells. J Nat Prod 76(8):1413–1423. https://doi.org/10.1021/np400172k
Burmistrova O, Perdomo J, Simões MF, Rijo P, Quintana J, Estévez F (2015) The abietane diterpenoid parvifloron D from Plectranthus ecklonii is a potent apoptotic inducer in human leukemia cells. Phytomedicine 22:1009–1016. https://doi.org/10.1016/j.phymed.2015.06.013
Cagel M, Grotz E, Bernabeu E, Moretton MA, Chiappetta DA (2017) Doxorubicin: nanotechnological overviews from bench to bedside. Drug Discov Today 22(2):270–281. https://doi.org/10.1016/j.drudis.2016.11.005
Chen Y, Mohanraj VJ, Parkin JE (2003) Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis. Lett Pept Sci 10:621–629. https://doi.org/10.1007/BF02442596
Chen Y, Mohanraj VJ, Wang F, Benson HAE (2007) Designing chitosan-dextran sulfate nanoparticles using charge ratios. AAPS PharmSciTech 8(4):131–139. https://doi.org/10.1208/pt0804098
Chen Y, Lin X, Park H, Greever R (2009) Study of artemisinin nanocapsules as anticancer drug delivery systems. Nanomedicine 5(3):316–322. https://doi.org/10.1016/j.nano.2008.12.005
Chorilli M, Brizante AC, Rodrigues CA, Regina H, Salgado N (2007) Aspectos gerais em sistemas transdérmicos de liberação de fármacos [General aspects in transdermal systems of drugs release]. Rev Bras Farm 88(1):7–13
Chuan L, Jia Z, Yu-Jiao Z, Shu-Fang N, Jun C, Qian W et al (2015) Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals. Chin J Nat Med 13(9):641–652. https://doi.org/10.1016/S1875-5364(15)30061-3
Cyprych K, Sznitko L, Mysliwiec J (2014) Starch: application of biopolymer in random lasing. Organic Electron Phys Mater Appl 15(10):2218–2222. https://doi.org/10.1016/j.orgel.2014.06.027
Davis T, Farag SS (2013) Treating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristine. Int J Nanomedicine 8:3479–3488. https://doi.org/10.2147/IJN.S47037
Debergh I, Van Damme N, Pattyn P, Peeters M, Ceelen WP (2010) The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model. Br J Cancer 102(5):837–843. https://doi.org/10.1038/sj.bjc.6605535
Dev A, Binulal NS, Anitha A, Nair SV, Furuike T, Tamura H, Jayakumar R (2010) Preparation of poly(lactic acid)/chitosan nanoparticles for anti-HIV drug delivery applications. Carbohydr Polym 80(3):833–838. https://doi.org/10.1016/j.carbpol.2009.12.040
Din FU, Aman W, Ullah I, Qureshi OS, Mustapha O, Shafique S, Zeb A (2017) Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomedicine 12:7291–7309. https://doi.org/10.2147/IJN.S146315
Djagny KB, Wang Z, Xu S (2001) Gelatin: a valuable protein for food and pharmaceutical industries: review. Crit Rev Food Sci Nutr 41(6):481–492. https://doi.org/10.1080/20014091091904
Douer D (2016) Efficacy and safety of vincristine sulfate liposome injection in the treatment of adult acute lymphocytic leukemia. Oncologist 21(7):840–847. https://doi.org/10.1634/theoncologist.2015-0391
Dykman LA, Khlebtsov NG (2011) Gold nanoparticles in biology and medicine: recent advances and prospects. Acta Nat 3(2):34–55. https://doi.org/10.1039/c0cs00018c
Edmundson MC, Capeness M, Horsfall L (2014) Exploring the potential of metallic nanoparticles within synthetic biology. New Biotechnol 31(6):572–577. https://doi.org/10.1016/j.nbt.2014.03.004
Elzoghby AO (2013) Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research. J Control Release 172(3):1075–1091. https://doi.org/10.1016/j.jconrel.2013.09.019
Elzoghby AO, Samy WM, Elgindy NA (2012) Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release 157(2):168–182. https://doi.org/10.1016/j.jconrel.2011.07.031
Frantz C, Stewart KM, Weaver VM (2010) The extracellular matrix at a glance. J Cell Sci 123(24):4195–4200. https://doi.org/10.1242/jcs.023820
Ganesan P, Arulselvan P, Choi D-K (2017) Phytobioactive compound-based nanodelivery systems for the treatment of type 2 diabetes mellitus – current status. Int J Nanomedicine 12:1097–1111. https://doi.org/10.2147/IJN.S124601
Gao Y, Wang J, Wang Y, Yin Q, Glennon B, Zhong J et al (2015) Crystallization methods for preparation of nanocrystals for drug delivery system. Curr Pharm Des 21(22):3131–3139. https://doi.org/10.2174/1381612821666150531164350
Gasco MR, Gallarate M, Trotta M, Bauchiero L, Gremmo E, Chiappero O (1989) Microemulsions as topical delivery vehicles: ocular administration of timolol. J Pharm Biomed Anal 7(4):433–439. https://doi.org/10.1016/0731-7085(89)80030-5
Gaspar-Marques C, Simões MF, Valdeira ML, Rodríguez B (2008) Terpenoids and phenolics from Plectranthus strigosus, bioactivity screening. Nat Prod Res 22(2):167–177. https://doi.org/10.1080/14786410701654560
Goyal A, Kumar S, Nagpal M, Singh I, Arora S (2011) Potential of novel drug delivery Systems for Herbal Drugs. Drugs 45(3):225–235
Grandhi BK, Thakkar A, Wang J, Prabhu S (2014) A novel combinatorial nanotechnology-based Oral Chemopreventive regimen demonstrates significant suppression of pancreatic Cancer neoplastic lesions. Cancer Prev Res 6(10):1015–1025. https://doi.org/10.1097/MPG.0b013e3181a15ae8.Screening
Gregoriadis G (2016) Liposomes in drug delivery: how it all happened. Pharmaceutics 8(19):1–5. https://doi.org/10.3390/pharmaceutics8020019
Gupta A, Eral HB, Hatton TA, Doyle S, P. (2016) Nanoemulsions: formation, properties and applications. Soft Matter 12(8):2826–2841. https://doi.org/10.1039/b000000x
Han S, Li M, Liu X, Gao H, Wu Y (2013) Construction of amphiphilic copolymer nanoparticles based on gelatin as drug carriers for doxorubicin delivery. Colloids Surf B: Biointerfaces 102:833–841. https://doi.org/10.1016/j.colsurfb.2012.09.010
Havel H, Finch G, Strode P, Wolfgang M, Zale S, Bobe I et al (2016) Nanomedicines: from bench to bedside and beyond. AAPS J 18(6):1373–1378. https://doi.org/10.1208/s12248-016-9961-7
Hawary DL, Motaleb MA, Farag H, Guirguis OW, Elsabee MZ (2011) Water-soluble derivatives of chitosan as a target delivery system of 99mTc to some organs in vivo for nuclear imaging and biodistribution. J Radioanal Nucl Chem 290(3):557–567. https://doi.org/10.1007/s10967-011-1310-9
Ho YC, Wu SJ, Mi FL, Chiu YL, Yu SH, Panda N, Sung HW (2010) Thiol-modified chitosan sulfate nanoparticles for protection and release of basic fibroblast growth factor. Bioconjug Chem 21(1):28–38. https://doi.org/10.1021/bc900208t
Honda M, Asai T, Oku N, Araki Y, Tanaka M, Ebihara N (2013) Liposomes and nanotechnology in drug development: focus on ocular targets. Int J Nanomedicine 8:495–504. https://doi.org/10.2147/IJN.S30725
Hou L, Yao J, Zhou J, Zhang Q (2012) Pharmacokinetics of a paclitaxel-loaded low molecular weight heparin-all-trans-retinoid acid conjugate ternary nanoparticulate drug delivery system. Biomaterials 33(21):5431–5440. https://doi.org/10.1016/j.biomaterials.2012.03.070
Hou Z, Li Y, Huang Y, Zhou C, Lin J, Wang Y et al (2013) Phytosomes loaded with mitomycin C-soybean phosphatidylcholine complex developed for drug delivery. Mol Pharm 10(1):90–101. https://doi.org/10.1021/mp300489p
Huang X, Huang G, Zhang S, Sagiyama K, Togao O, Ma X et al (2013) Multi-chromatic pH-activatable 19F-MRI nanoprobes with binary ON/OFF pH transitions and chemical-shift barcodes. Angewandte Chemie – Int Ed 52(31):8074–8078. https://doi.org/10.1002/anie.201301135
Islan GA, Durán M, Cacicedo ML, Nakazato G, Kobayashi RKT, Martinez DST et al (2017) Nanopharmaceuticals as a solution to neglected diseases: is it possible? Acta Trop 170:16–42. https://doi.org/10.1016/j.actatropica.2017.02.019
Jahanshahi M, Babaei Z (2008) Protein nanoparticle: a unique system as drug delivery vehicles. Afr J Biotechnol 7(25):4926–4934. https://doi.org/10.4314/ajb.v7i25.59701
Jaiswal M, Dudhe R, Sharma PK (2015) Nanoemulsion: an advanced mode of drug delivery system. 3. Biotech 5(2):123–127. https://doi.org/10.1007/s13205-014-0214-0
Junghanns JUAH, Müller RH (2008) Nanocrystal technology, drug delivery and clinical applications. Int J Nanomedicine 3(3):295–309. https://doi.org/10.2147/IJN.S595
Jurj A, Braicu C, Pop L-A, Tomuleasa C, Gherman CD, Berindan-Neagoe I (2017) The new era of nanotechnology, an alternative to change cancer treatment. Drug Des Devel Ther 11:2871–2890. https://doi.org/10.2147/DDDT.S142337
Kakino Y, Hishikawa Y, Onodera R, Tahara K (2017) Gelation factors of pectin for development of a powder form of gel, dry jelly, as a novel dosage form. Chem Pharm Bull 65(11):1035–1044. https://doi.org/10.1248/cpb.c17-00447
Kakkar V, Singh S, Singla D, Kaur IP (2011) Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol Nutr Food Res 55(3):495–503. https://doi.org/10.1002/mnfr.201000310
Khan J, Alexander A, Ajazuddin, Saraf S, Saraf S (2013a) Recent advances and future prospects of phyto-phospholipid complexation technique for improving pharmacokinetic profile of plant actives. J Control Release 168(1):50–60. https://doi.org/10.1016/j.jconrel.2013.02.025
Khan S, De Matas M, Zhang J, Anwar J (2013b) Nanocrystal preparation: low-energy precipitation method revisited. Cryst Growth Des 13(7):2766–2777. https://doi.org/10.1021/cg4000473
Khandare JJ, Jayant S, Singh A, Chandna P, Wang Y, Vorsa N, Minko T (2006) Dendrimer versus linear conjugate: influence of polymeric architecture on the delivery and anticancer effect of paclitaxel. Bioconjug Chem 17(6):1464–1472. https://doi.org/10.1021/bc060240p
Koroleva MY, Yurtov EV (2012) Nanoemulsions: the properties, methods of preparation and promising applications. Russ Chem Rev 81(1):21–43. https://doi.org/10.1070/RC2012v081n01ABEH004219
Kratz F (2008) Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release 132(3):171–183. https://doi.org/10.1016/j.jconrel.2008.05.010
Kuen C, Fakurazi S, Othman S, Masarudin M (2017) Increased loading, efficacy and sustained release of Silibinin, a poorly soluble drug using Hydrophobically-modified chitosan nanoparticles for enhanced delivery of anticancer drug delivery systems. Nano 7(11):379. https://doi.org/10.3390/nano7110379
Kumar AS, Gupta A (2015) A review on nanotized herbal drugs. Int J Pharm Sci Res 6(3):961–970. https://doi.org/10.13040/IJPSR.0975-8232.6(3).961-70
Li J, Di Y, Jin C, Fu D, Yang F, Jiang Y et al (2013) Gemcitabine-loaded albumin nanospheres (GEM-ANPs) inhibit PANC-1 cells in vitro and in vivo. Nanoscale Res Lett 8(1):176. https://doi.org/10.1186/1556-276X-8-176
Li Y, Liu C, Tan Y, Xu K, Lu C, Wang P (2014) In situ hydrogel constructed by starch-based nanoparticles via a Schiff base reaction. Carbohydr Polym 110:87–94. https://doi.org/10.1016/j.carbpol.2014.03.058
Litzinger DC, Buiting AMJ, van Rooijen N, Huang L (1994) Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. BBA-Biomembranes 1190(1):99–107. https://doi.org/10.1016/0005-2736(94)90038-8
Liu Y, Feng N (2015) Nanocarriers for the delivery of active ingredients and fractions extracted from natural products used in traditional Chinese medicine (TCM). Adv Colloid Interf Sci 221:60–76. https://doi.org/10.1016/j.cis.2015.04.006
Lofgren C, Hermansson AM (2007) Synergistic rheological behaviour of mixed HM/LM pectin gels. Food Hydrocoll 21(3):480–486. https://doi.org/10.1016/j.foodhyd.2006.07.005
Lu X-Y, Wu D-C, Li Z-J, Chen G-Q (2011) Polymer nanoparticles. Progress in molecular biology and translational science, vol 104, 1st edn. Elsevier Inc. https://doi.org/10.1016/B978-0-12-416020-0.00007-3
Madhuri S, Pandey G (2009) Some anticancer medicinal plants of foreign origin. Curr Sci 96(6):779–783
Mainardes RM, Urban MCC, Cinto PO, Chaud MV, Evangelista RC, Gremião MPD (2006) Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery. Curr Drug Deliv 3(August):275–285. https://doi.org/10.2174/156720106777731019
Majoros IJ, Myc A, Thomas T, Mehta CB, Baker JR (2006) PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Biomacromolecules 7(2):572–579. https://doi.org/10.1021/bm0506142
Manconi M, Marongiu F, Castangia I, Manca ML, Caddeo C, Tuberoso CIG et al (2016) Polymer-associated liposomes for the oral delivery of grape pomace extract. Colloids Surf B: Biointerfaces 146:910–917. https://doi.org/10.1016/j.colsurfb.2016.07.043
Marques Neto LM, Kipnis A, Junqueira-Kipnis AP (2017) Role of metallic nanoparticles in vaccinology: implications for infectious disease vaccine development. Front Immunol 8(239):1–10. https://doi.org/10.3389/fimmu.2017.00239
Marslin G, Siram K, Liu X, Khandelwal VKM, Xiaolei S, Xiang W, Franklin G (2017) Solid lipid nanoparticles of Albendazole for enhancing cellular uptake and cytotoxicity against U-87 MG glioma cell lines. Molecules 22(2040):1–9. https://doi.org/10.3390/molecules22112040
Matias D, Roque L, De Fátima Simões M, Diaz-Lanza A, Rijo P, Reis CP (2015) Plectranthus madagascariensis phytosomes: formulation optimization. Biomed Biopharm Res 12(2):223–231. Retrieved from http://www.biomedicalandbiopharmaceuticalresearch.com
Matias D, Rijo P, Reis CP (2016) Phytosomes as biocompatible carriers of natural drugs. Curr Med Chem 23:1–29. https://doi.org/10.2174/0929867323666161028
Mimi H, Ho KM, Siu YS, Wu A, Li P (2012) Polyethyleneimine-based Core-Shell Nanogels: a promising siRNA carrier for Argininosuccinate Synthetase mRNA knockdown in HeLa cells. J Control Release 158(1):123–130. https://doi.org/10.1016/j.jconrel.2011.10.035
Mody V, Siwale R, Singh A, Mody H (2010) Introduction to metallic nanoparticles. J Pharm Bioallied Sci 2(4):282–289. https://doi.org/10.4103/0975-7406.72127
Mota AH, Rijo P, Molpeceres J, Reis CP (2017) Broad overview of engineering of functional nanosystems for skin delivery. Int J Pharm 532(2):710–728. https://doi.org/10.1016/j.ijpharm.2017.07.078
Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA et al (2005) Antiangiogenic properties of gold nanoparticles. Clin Cancer Res 11(9):3530–3535
Müller RH, Junghanns J-UAH (2006) Drug nanocrystals/Nanosuspensions for the delivery of poorly soluble drugs. In: Nanoparticulates as drug carriers. Published by Imperial College Press and distributed by World Scientific Publishing Co, pp 307–328. https://doi.org/10.1142/9781860949074_0014
Muruci de Paula K, Lopez da Silva L (2016) Applications of pectin: a multipurpose biomolecule. Austin Biomol Open Access 1(2):1–2
Mutoh T, Mutoh T, Taki Y, Ishikawa T (2016) Therapeutic potential of natural product-based oral nanomedicines for stroke prevention. J Med Food 19(6):521–527. https://doi.org/10.1089/jmf.2015.3644
Nair R, Reddy BH, Kumar CKA, Kumar KJ (2009) Application of chitosan microspheres as drug carriers: a review. J Pharm Sci Res 1(2):1–12
Nakamura H, Jun F, Maeda H (2015) Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls. Expert Opin Drug Deliv 12(1):53–64. https://doi.org/10.1517/17425247.2014.955011
Namdari M, Eatemadi A, Soleimaninejad M, Hammed AT (2017) A brief review on the application of nanoparticle enclosed herbal medicine for the treatment of infective endocarditis. Biomed Pharmacother 87:321–331. https://doi.org/10.1016/j.biopha.2016.12.099
Natesan S, Sugumaran A, Ponnusamy C, Thiagarajan V, Palanichamy R, Kandasamy R (2017) Chitosan stabilized camptothecin nanoemulsions: development, evaluation and biodistribution in preclinical breast cancer animal mode. Int J Biol Macromol 104:1846–1852. https://doi.org/10.1016/j.ijbiomac.2017.05.127
Nguyen S, Alund SJ, Hiorth M, Kjøniksen AL, Smistad G (2011) Studies on pectin coating of liposomes for drug delivery. Colloids Surf B: Biointerfaces 88(2):664–673. https://doi.org/10.1016/j.colsurfb.2011.07.058
Nurunnabi M, Khatun Z, Moon W-C, Lee G, Lee Y-K (2012) Heparin based nanoparticles for cancer targeting and noninvasive imaging. Quant Imaging Med Surg 2(3):219–226. https://doi.org/10.3978/j.issn.2223-4292.2012.09.01
Padmavathi M (2013) Drug delivery system in Nano greens. Int J Herbal Med 1(3):56–60
Park IK, Kim YJ, Tran TH, Huh KM, Lee YK (2010) Water-soluble heparin-PTX conjugates for cancer targeting. Polymer 51(15):3387–3393. https://doi.org/10.1016/j.polymer.2010.05.030
Passirani C, Barratt G, Devissaguet JP, Labarre D (1998) Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate). Pharm Res 15:1046–1050. https://doi.org/10.1023/A:1011930127562
Pelaz B, Alexiou C, Alvarez-Puebla RA, Alves F, Andrews AM, Ashraf S et al (2017) Diverse applications of nanomedicine. ACS Nano 11(3):2313–2381. https://doi.org/10.1021/acsnano.6b06040
Pestana KC, Formariz TP, Franzini CM, Sarmento VHV, Chiavacci LA, Scarpa MV et al (2008) Oil-in-water lecithin-based microemulsions as a potential delivery system for amphotericin B. Colloids Surf B: Biointerfaces 66(2):253–259. https://doi.org/10.1016/j.colsurfb.2008.06.016
Pinto Reis C, Neufeld RJ, Ribeiro AJ, Veiga F (2006) Nanoencapsulation I. methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine 2(1):8–21. https://doi.org/10.1016/j.nano.2005.12.003
Pinto Reis C, Silva C, Martinho N, Rosado C (2013) Drug carriers for oral delivery of peptides and proteins: accomplishments and future perspectives. Ther Deliv 4(February):251–265. https://doi.org/10.4155/tde.12.143
Prabhu S, Poulose EK (2012) Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects. Int Nano Lett 2(32):1–10. https://doi.org/10.1186/2228-5326-2-32
Prabhu RH, Patravale VB, Joshi MD (2015) Polymeric nanoparticles for targeted treatment in oncology: current insights. Int J Nanomedicine 10:1001–1018. https://doi.org/10.2147/IJN.S56932
Ragelle H, Danhier F, Préat V, Langer R, Anderson DG (2017) Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures. Expert Opin Drug Deliv 14(7):851–864. https://doi.org/10.1080/17425247.2016.1244187
Rao JP, Geckeler KE (2011) Polymer nanoparticles: preparation techniques and size-control parameters. Prog Polym Sci (Oxford) 36(7):887–913. https://doi.org/10.1016/j.progpolymsci.2011.01.001
Raveendran S, Yoshida Y, Maekawa T, Kumar DS (2013) Pharmaceutically versatile sulfated polysaccharide based bionano platforms. Nanomedicine 9(5):605–626. https://doi.org/10.1016/j.nano.2012.12.006
Raveendran S, Rochani AK, Maekawa T, Kumar DS (2017) Smart carriers and Nanohealers: a nanomedical insight on natural polymers. Materials 10(8). https://doi.org/10.3390/ma10080929
Rebelo A, Molpeceres J, Rijo P, Reis CP (2017) Pancreatic Cancer therapy review: from classic therapeutic agents to modern nanotechnologies. Curr Drug Metab. https://doi.org/10.2174/1389200218666170201151135
Reis CP, Figueiredo IV, Carvalho R a, Jones J, Nunes P, Soares AF et al (2008a) Toxicological assessment of orally delivered nanoparticulate insulin. Nanotoxicology 2(4):205–217. https://doi.org/10.1080/17435390802398309
Reis CP, Ribeiro AJ, Veiga F, Neufeld RJ, Damgé C (2008b) Polyelectrolyte biomaterial interactions provide nanoparticulate carrier for oral insulin delivery. Drug Deliv 15(2):127–139. https://doi.org/10.1080/10717540801905165
Reis CP, Veiga FJ, Ribeiro AJ, Neufeld RJ, Damgé C (2008c) Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response. J Pharm Sci 97(12):5290–5305. https://doi.org/10.1002/jps.21347
Rivera Gil P, Hühn D, del Mercato LL, Sasse D, Parak WJ (2010) Nanopharmacy: inorganic nanoscale devices as vectors and active compounds. Pharmacol Res 62(2):115–125. https://doi.org/10.1016/j.phrs.2010.01.009
Rolland JP, Maynor BW, Euliss LE, Exner AE, Denison GM, Desimone JM, Nanobiomaterials S (2005) Direct fabrication and harvesting of direct fabrication and harvesting of monodisperse. J Am Chem Soc 127(28):10096–10100. https://doi.org/10.1021/ja051977c
Rosa S, Correia V, Ribeiro I, Rijo P, Saraiva N, Fernandes A (2015) In vitro antioxidant properties of the diterpenes Parvifloron D and 7α-acetoxy-6β- hydroxyroyleanone. Biomédica e Biofarnacêutica 12(1):59–67. https://doi.org/10.19277/bbr.12.1.104
Sahoo NG, Kakran M, Shaal LA, Li L, Muller RH, Pal M, Tan LP (2011) Preparation and characterization of quercetin nanocrystals. J Pharm Sci 100(6):1997–2515. https://doi.org/10.1002/jps
Sannaa V, Siddiquia IA, Sechia M, Mukhtara H (2012) Nanoformulation of natural products for prevention and therapy of prostate cancer. Cancer Lett 334(1):142–151. https://doi.org/10.1086/498510.Parasitic
Sarvaiya J, Agrawal YK (2015) Chitosan as a suitable nanocarrier material for anti-Alzheimer drug delivery. Int J Biol Macromol 72:454–465. https://doi.org/10.1016/j.ijbiomac.2014.08.052
Sasidharan S, Chen Y, Saravanan D, Sundram KM, Yoga Latha L (2011) Extraction, isolation and characterization of bioactive compounds from plants’ extracts. Afr J Tradit Complement Altern Med 8(1):1–10. https://doi.org/10.4314/ajtcam.v8i1.60483
Schnitzer JE (1992) Gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis. Am J Phys 262(1 Pt 2):H246–H254
Schnitzerlt JE, Ulmer JB, Paladel E (1992) Common peptide epitopes in glycophorin and the endothelial sialoglycoprotein gp60. Biochem Biophys Res Commun 187(16):1158–1165. https://doi.org/10.1016/0006-291X(92)91318-K
Semalty A, Semalty M, Rawat MSM, Franceschi F (2010) Supramolecular phospholipids-polyphenolics interactions: the PHYTOSOME® strategy to improve the bioavailability of phytochemicals. Fitoterapia 81(5):306–314. https://doi.org/10.1016/j.fitote.2009.11.001
Shafei A, El-Bakly W, Sobhy A, Wagdy O, Reda A, Aboelenin O et al (2017) A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer. Biomed Pharmacother 95:1209–1218. https://doi.org/10.1016/j.biopha.2017.09.059
She W, Li N, Luo K, Guo C, Wang G, Geng Y, Gu Z (2013) Dendronized heparin-doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy. Biomaterials 34(9):2252–2264. https://doi.org/10.1016/j.biomaterials.2012.12.017
Silva CO, Rijo P, Molpeceres J, Figueiredo IV, Ascensão L, Fernandes AS et al (2015) Polymeric nanoparticles modified with fatty acids encapsulating betamethasone for anti-inflammatory treatment. Int J Pharm 493(1–2):271–284. https://doi.org/10.1016/j.ijpharm.2015.07.044
Silva CO, Molpeceres J, Batanero B, Fernandes AS, Saraiva N, Costa JG et al (2016a) Functionalized diterpene parvifloron D-loaded hybrid nanoparticles for targeted delivery in melanoma therapy. Ther Deliv 7(8):521–544. https://doi.org/10.4155/tde-2016-0027
Silva CO, Rijo P, Molpeceres J, Ascensão L, Roberto A, Fernandes AS et al (2016b) Bioproduction of gold nanoparticles for photothermal therapy. Ther Deliv 7(5):287–304. https://doi.org/10.4155/tde-2015-0011
Silverman JA, Deitcher SR (2013) Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine. Cancer Chemother Pharmacol 71(3):555–564. https://doi.org/10.1007/s00280-012-2042-4
Simões MF, Rijo P, Duarte A, Matias D, Rodríguez B (2010) An easy and stereoselective rearrangement of an abietane diterpenoid into a bioactive microstegiol derivative. Phytochem Lett 3:234–237. https://doi.org/10.1016/j.phytol.2010.09.001
Singh Y, Meher JG, Raval K, Khan FA, Chaurasia M, Jain NK, Chourasia MK (2017) Nanoemulsion: concepts, development and applications in drug delivery. J Control Release 252:28–49. https://doi.org/10.1016/j.jconrel.2017.03.008
Sinha VR, Kumria R (2001) Polysaccharides in colon-specific drug delivery. Int J Pharm 224(1–2):19–38. https://doi.org/10.1016/S0378-5173(01)00720-7
Sintov AC, Shapiro L (2004) New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo. J Control Release 95(2):173–183. https://doi.org/10.1016/j.jconrel.2003.11.004
Song L, Shen Y, Hou J, Lei L, Guo S, Qian C (2011) Polymeric micelles for parenteral delivery of curcumin: preparation, characterization and in vitro evaluation. Colloids Surf A Physicochem Eng Asp 390(1–3):25–32. https://doi.org/10.1016/j.colsurfa.2011.08.031
Sutaria D, Grandhi BK, Thakkar A, Wang J, Prabhu S (2012) Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen. Int J Oncol 41(6):2260–2268. https://doi.org/10.3892/ijo.2012.1636
Tan M, He C, Jiang W, Zeng C, Yu N, Huang W et al (2017) Development of solid lipid nanoparticles containing total flavonoid extract from Dracocephalum moldavica L. and their therapeutic effect against myocardial ischemia–reperfusion injury in rats. Int J Nanomedicine 12:3253–3265. https://doi.org/10.2147/IJN.S131893
Tana ML, Choonga PFM, Dass CR (2009) Review : doxorubicin delivery systems based on chitosan for cancer therapy. J Pharm Pharmacol 61(2):131–142. https://doi.org/10.1211/jpp/61.02.0001
Thakkar KN, Mhatre SS, Parikh RY (2010) Biological synthesis of metallic nanoparticles. Nanomedicine 6(2):257–262. https://doi.org/10.1016/j.nano.2009.07.002
Truong-Le VL, Walsh SM, Schweibert E, Mao HQ, Guggino WB, August JT, Leong KW (1999) Gene transfer by DNA-gelatin nanospheres. Arch Biochem Biophys 361(1):47–56. https://doi.org/10.1006/abbi.1998.0975
Tyagi N, De R, Begun J, Popat A (2017) Cancer therapeutics with epigallocatechin-3-gallate encapsulated in biopolymeric nanoparticles. Int J Pharm 518(1–2):220–227. https://doi.org/10.1016/j.ijpharm.2016.12.030
Urias-Orona V, Rascón-Chu A, Lizardi-Mendoza J, Carvajal-Millán E, Gardea AA, Ramírez-Wong B (2010) A novel pectin material: extraction, characterization and gelling properties. Int J Mol Sci 11(10):3686–3695. https://doi.org/10.3390/ijms11103686
Van Eerdenbrugh B, Van den Mooter G, Augustijns P (2008) Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm 364(1):64–75. https://doi.org/10.1016/j.ijpharm.2008.07.023
Venkatesan J, Bhatnagar I, Manivasagan P, Kang K-H, Kim S-K (2015) Alginate composites for bone tissue engineering: a review. Int J Biol Macromol 72:269–281. https://doi.org/10.1016/j.ijbiomac.2014.07.008
Ventola CL (2012) The nanomedicine revolution: part 3: regulatory and safety challenges. Pharm Ther 37(11):631–639. Retrieved from http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L365923360
Ventola CL (2017) Progress in nanomedicine: approved and investigational Nanodrugs. P & T: A Peer-Rev J Formul Manag 42(12):742–755. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/29234213%0A. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5720487
Vigneshwaran N, Nachane RP, Balasubramanya RH, Varadarajan PV (2006) A novel one-pot “green” synthesis of stable silver nanoparticles using soluble starch. Carbohydr Res 341(12):2012–2018. https://doi.org/10.1016/j.carres.2006.04.042
Wang H, Yu J, Lu X, He X (2016) Nanoparticle systems reduce systemic toxicity in cancer treatment. Nanomedicine (Lond) 11(2):103–106. https://doi.org/10.2217/nnm.15.166
Watkins R, Wu L, Zhang C, Davis RM, Xu B (2015) Natural product-based nanomedicine: recent advances and issues. Int J Nanomedicine 10:6055–6074. https://doi.org/10.2147/IJN.S92162
Weissig V, Pettinger TK, Murdock N (2014) Nanopharmaceuticals (part 1): products on the market. Int J Nanomedicine 9:4357–4373. https://doi.org/10.2147/IJN.S46900
Wilson MW, Kerlan RK, Fidelman NA, Venook AP, Laberge JM, Koda J, Gordon RL (2004) Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/conventional angiography suite – initial experience with four patients. Radiology 230:287–293. https://doi.org/10.1148/radiol.2301021493
Wu QX, Lin DQ, Yao SJ (2014) Design of chitosan and its water soluble derivatives-based drug carriers with polyelectrolyte complexes. Mar Drugs 12(12):6236–6253. https://doi.org/10.3390/md12126236
Wu D, Si M, Xue H-Y, Wong H-L (2017) Nanomedicine applications in the treatment of breast cancer: current state of the art. Int J Nanomedicine 12:5879–5892. https://doi.org/10.2147/IJN.S123437
Yang L, Chen L, Zeng R, Li C, Qiao R, Hu L, Li Z (2010) Synthesis, nanosizing and in vitro drug release of a novel anti-HIV polymeric prodrug: chitosan-O-isopropyl-5′-O-d4T monophosphate conjugate. Bioorg Med Chem 18(1):117–123. https://doi.org/10.1016/j.bmc.2009.11.013
Yang J, Huang Y, Gao C, Liu M, Zhang X (2014) Fabrication and evaluation of the novel reduction-sensitive starch nanoparticles for controlled drug release. Colloids Surf B: Biointerfaces 115:368–376. https://doi.org/10.1016/j.colsurfb.2013.12.007
Yang L, Xin J, Zhang Z, Yan H, Wang J, Sun E et al (2016) TPGS-modified liposomes for the delivery of ginsenoside compound K against non-small cell lung cancer: formulation design and its evaluation in vitro and in vivo. J Pharm Pharmacol 69(9):1093–1232. https://doi.org/10.1111/jphp.12590
Yu H, Huang Q (2010) Bioavailability and delivery of nutraceuticals and functional foods using nanotechnology. J Food Sci 75(1):593–604. https://doi.org/10.1002/9781118451915.ch35
Yu X, Jin C (2016) Application of albumin-based nanoparticles in the management of cancer. J Mater Sci Mater Med 27(4):1–10. https://doi.org/10.1007/s10856-015-5618-9
Yu X, Di Y, Xie C, Song Y, He H, Li H et al (2015) An in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line. Int J Nanomedicine 10:6825–6834. https://doi.org/10.2147/IJN.S93835
Yu X, Zhu W, Di Y, Gu J, Guo Z, Li H et al (2017) Triple-functional albumin-based nanoparticles for combined chemotherapy and photodynamic therapy of pancreatic cancer with lymphatic metastases. Int J Nanomedicine 12:6771–6785. https://doi.org/10.2147/IJN.S131295
Zhang Y, Chen T, Yuan P, Tian R, Hu W, Tang Y et al (2015) Encapsulation of honokiol into self-assembled pectin nanoparticles for drug delivery to HepG2 cells. Carbohydr Polym 133:31–38. https://doi.org/10.1016/j.carbpol.2015.06.102
Zhi J, Wang Y, Lu Y, Ma J, Luo G (2006) In situ preparation of magnetic chitosan/Fe3O4 composite nanoparticles in tiny pools of water-in-oil microemulsion. React Funct Polym 66(12):1552–1558. https://doi.org/10.1016/j.reactfunctpolym.2006.05.006
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Santos-Rebelo, A. et al. (2021). Natural Products and Nanopharmaceuticals. In: Yata, V., Ranjan, S., Dasgupta, N., Lichtfouse, E. (eds) Nanopharmaceuticals: Principles and Applications Vol. 2. Environmental Chemistry for a Sustainable World, vol 47. Springer, Cham. https://doi.org/10.1007/978-3-030-44921-6_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-44921-6_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-44920-9
Online ISBN: 978-3-030-44921-6
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)